NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/14/2025
Back to search
Official data from USPTO
IMMUNOSCORE IC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
IMMUNOSCORE IC
ST13
US500000079342738Class
5, 9, 42, 44
Filing
79342738
Registration
7318047
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
08/15/2025
Trademark type
Word
Nice classes
5, 9, 42, 44
Filing date
04/29/2022
Registration date
03/05/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/05/2024
Last transaction
08/15/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
34
Owner location
FR
Examiner
EISNACH, MICHAEL
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
VERACYTE
Representatives
Rosaleen H. Chou Knobbe, Martens, Olson & Bear, LLP
Technical classification
Nice Classes
Class 5Class 9Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical productspharmaceutical products for use in the treatment of cancer; chemical preparations for medical and pharmaceutical usenamely for use in the treatment of cancer; biological reagents for medical use for providing information on diagnostics or identification of biological systems; biological reagents for providing information on diagnostics or identification of biological systems for medical use; immunological reagents for medical use; biological reagents for medical diagnosis; diagnostic kits comprising medical diagnostic reagents and medical diagnostic tests for the diagnosis of cancer and for the evaluation of a patient's reaction time to cancer treatments; biological reagents for medical research; biological reagents for medical use; biological reagents for clinical diagnosis
Class 9
Downloadable or recorded software for diagnosisprognosismonitoringprediction of reactions to treatment and continuous evaluation analysis and study of a cancer or tumors; downloadable application software in the field of clinical biology for diagnosisprognosismonitoringprediction of reactions to treatment and continuous evaluation analysis and study of a cancer or tumors
Class 42
Researchdevelopmenttechnical design and scientific testing servicesnamely scientific research for relating to cancer treatment; industrial analysis and research services in the fields of immuno-oncology and cancer research; clinical trial servicesnamely providing laboratory testing in clinical trials; tests in laboratoriesnamely in the fields of immuno-oncology and cancer research; development of testing methods for others in the fields of immuno-oncology and cancer research; researchdevelopmenttechnical designtestingconsultancy and analysis services in the field of immuno-oncology; research services in the field of genome and immune index analysis; design and development of software in the field of biology
Class 44
Medical analysis services for the diagnosis of cancer and for the evaluation of a patient's reaction time to cancer treatments; medical assistance; medical diagnostics and diagnostics in the field of medicinenamely in the fields of immuno-oncology and cancer research; genetic analysis servicesnamely in the fields of immuno-oncology and cancer research
Publications
History of USPTO decisions and trademark events.
26 publications found
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/06/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/05/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
03/05/2024
GPNX
NOTIFICATION PROCESSED BY IB
12/19/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/19/2023
PUBO
PUBLISHED FOR OPPOSITION
12/19/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/11/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/29/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/29/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/29/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/22/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/22/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/09/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/19/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/18/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/18/2023
RFNT
REFUSAL PROCESSED BY IB
05/10/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/18/2023
RFRR
REFUSAL PROCESSED BY MPU
04/18/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/28/2023
CNRT
NON-FINAL ACTION WRITTEN
02/27/2023
DOCK
ASSIGNED TO EXAMINER
02/17/2023
MAFR
APPLICATION FILING RECEIPT MAILED
06/21/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/17/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/16/2022
Continuous trademark protection
Get notified about every new filing that threatens IMMUNOSCORE IC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.